Prevalence and Associated Factors of Diabetes Mellitus Among Newly Enrolled Tuberculosis Patients in Lubumbashi (DRC)
Christian Kakisingi,Claude Mwamba,Michel Muteba,Eric Kasamba,Michel Kabamba,Aristophane Tanon,Hippolyte Situakibanza
DOI: https://doi.org/10.2147/rmhp.s436873
2024-01-18
Risk Management and Healthcare Policy
Abstract:Christian Kakisingi, 1 Claude Mwamba, 1 Michel Kasongo Muteba, 2 Eric Kasamba, 3 Michel Kabamba, 4 Aristophane Tanon, 5 Hippolyte Situakibanza 6 1 Internal Medicine Department, University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo; 2 Division of Epidemiology and Biostatistics, University ofWitwatersrand, Johannesburg, Republic of South Africa; 3 Department of Basics Sciences. University of Lubumbashi, Lubumbashi, Democratic Republic of the Congo; 4 Public Health Department, University of Kamina, Kamina, Democratic Republic of the Congo; 5 Specialities and Medicine Department, University of Félix Houphouët-Boigny of Abidjan Cocody, Abidjan, Ivory Coast; 6 Internal Medicine Department, Tropical Diseases, Infectious and Parasitic Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo Correspondence: Christian Kakisingi, Email Background: Tuberculosis and diabetes mellitus are major public health challenges worldwide. The two scourges have bidirectional relationship with high morbidity and mortality. Objective: The present study was conducted to determine the prevalence of diabetes mellitus and identify related factors in patients with tuberculosis. Methods: A cross-sectional study was conducted in 11 tuberculosis screening and treatment centers in Lubumbashi (DRC) from September to December 2022. Adult patient with a positive smear for tuberculosis were systematically screened for diabetes mellitus. Demographic characteristics, history and symptomatology were the variables of interest. Data was entered using Microsoft Excel software. STATA 16 software was used for analysis. Results: A total of 255 tuberculosis patients were recruited and the prevalence of diabetes mellitus among these patients was 11.4% (ie, 29 out of 255). After uni and multivariate logistic regression, a BMI ≤ 18.5 Kg/m2, lack of employment, polyuria and intense thirst were the factors associated with diabetes mellitus in tuberculosis patients. Conclusion: The prevalence of diabetes mellitus in smear positive tuberculosis patients in the present study was higher than the one observed in Central Africa. Keywords: tuberculosis, diabetes mellitus, comorbidity, prevalence, associated factors Tuberculosis (TB) is a contagious disease and of the top 10 killers worldwide. 1 Globally, an estimated 10.6 million (9.9–11 million) people have been infected with TB and 1.4 million (1.3–1.5 million) people have died of this disease in the year 2022. The Democratic Republic of Congo (DRC) is one of the 22 countries most affected by this condition. 2 Previous studies by Kakisingi et al 3,4 in the south of the DRC had shown the epidemiological impact of this scourge in terms of morbidity and mortality from this disease in Lubumbashi, in particular. Currently, non-communicable diseases (NCDs) constitute a growing global epidemic that disproportionately affects low- and middle-income countries (LMICs) where, at the same time, the impact of infectious diseases is high. 5 This phenomenon seems to be influenced by the advance of industrialization and urbanization which contribute to lifestyle changes, mainly in dietary habits, leading to increased rates of obesity and type 2 diabetes mellitus (DM). 6 And some authors estimate that the number of people living with DM type 2 should double between 2000 and 2030. 7 In the DRC, the prevalence of DM reported by the literature varies between 3.5 and 14% and nearly 23,000 deaths are attributed to DM. 6,8,9 Studies have shown that DM and TB are two overlapping diseases. 10,11 This strong coexistence is particularly accentuated in LMICs, where nearly 95% of the world's population with TB and 70% with DM live. 12,13 Systematic reviews suggest that people with DM are about three times more likely to develop TB than the general population. 11,14 Additionally, people with TB-DM comorbidity on anti-TB treatment have a higher risk of treatment failure and higher death compared to people with TB alone. 15 Worldwide, estimates of the prevalence of DM in TB patients differ depending on the geographic region and the socio-demographic characteristics of the patients examined. 5 And recent studies have shown that the prevalence of DM among patients with TB is variable depending on the series and regions. This varies from 50% compared to some studies carried out in India, to around 30% in Mexico, to less than 10% in the United States of America, and to even lower values in certain African countries such as Benin. (1.5%). 5,16,17 In t -Abstract Truncated-
health care sciences & services,health policy & services